Spots Global Cancer Trial Database for efgartigimod ph20 sc
Every month we try and update this database with for efgartigimod ph20 sc cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Evaluating the Long-Term Safety and Tolerability of Efgartigimod PH20 SC Administered Subcutaneously in Patients With Generalized Myasthenia Gravis | NCT04818671 | Generalized Mya... | efgartigimod PH... | 18 Years - | argenx | |
Evaluating the Long-Term Safety and Tolerability of Efgartigimod PH20 SC Administered Subcutaneously in Patients With Generalized Myasthenia Gravis | NCT04818671 | Generalized Mya... | efgartigimod PH... | 18 Years - | argenx |